Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

Ask Dr. Agus: COVID-19 public health emergency to end in May 04:00. Moderna will offer free COVID-19 vaccines for "uninsured or underinsured people," the company announced Wednesday, pledging to ...

Moderna has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use ...

Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political ...

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

Moderna CEO Stephane Bancel defended his company after it was reported that it is mulling a 400% price hike of its COVID vaccine. Bloomberg via Getty Images. In July, ...

Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...

The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the ...

The two companies collaborated on research showing quantum computing could greatly aid the design of mRNA-based medicines and ...

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its investigational mRNA therapeutics have been accepted for presentation at the ...

Moderna Chief Medical Officer Dr. Paul Burton told ABC News that he believes the company's "highly effective" updated COVID-19 bivalent vaccine could be a "turning point" in the nation's fight ...

Key Points Moderna has struggled since COVID-19 vaccine demand has shrunk.The stock has correspondingly declined, as revenue has nosedived over the last few years.The long game is clinical trials in ...